Pharmaceutical Giant Donating H1N1 Vaccines To Poor Countries

GlaxoSmithKline announced on Tuesday that they are giving 50 million doses of the swine flu vaccine to the World Health Organization, who will then give the medicines to developing countries in need.

The British pharmaceutical company has partnered with WHO and other health establishments to get the shipments of the H1N1 vaccine into the mail before December, they said in a statement.

“GSK is committed to supporting governments and health authorities around the world in their efforts to protect their populations against this pandemic,” said GSK chief executive Andrew Witty stated.